{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:59:57Z","timestamp":1790135997918,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.amjcard.2017.11.020","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T13:15:47Z","timestamp":1511788547000},"page":"461-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation"],"prefix":"10.1016","volume":"121","author":[{"given":"Tobias","family":"Rheude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3549-3007","authenticated-orcid":false,"given":"N. Patrick","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert M.","family":"Kasel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Holdenrieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicent","family":"Bodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Schunkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8284-2994","authenticated-orcid":false,"given":"Christian","family":"Hengstenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Husser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.11.020_bib0010","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0015","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0020","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1010-7940(99)00134-7","article-title":"European system for cardiac operative risk evaluation (EuroSCORE)","volume":"16","author":"Nashef","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0030","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.amjcard.2015.08.016","article-title":"Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation","volume":"116","author":"Koskinas","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0035","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.amjcard.2015.01.561","article-title":"Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER trial)","volume":"115","author":"O'Neill","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0040","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/ccd.25788","article-title":"N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement","volume":"85","author":"Stahli","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0045","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0735-1097(03)00311-5","article-title":"Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis","volume":"41","author":"Aloia","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jcin.2013.02.006","article-title":"Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation","volume":"6","author":"Husser","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.recesp.2016.07.027","article-title":"Improvement in risk stratification in transcatheter aortic valve implantation using a combination of the tumor marker CA125 and the logistic EuroSCORE","volume":"70","author":"Husser","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jtcvs.2012.09.002","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"145","author":"Kappetein","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0070","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.carrev.2011.04.005","article-title":"Comparison between Society of Thoracic Surgeons score and logistic EuroSCORE for predicting mortality in patients referred for transcatheter aortic valve implantation","volume":"12","author":"Ben-Dor","year":"2011","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0080","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2011.08.050","article-title":"Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry","volume":"58","author":"Moat","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/eurheartj\/ehn523","article-title":"Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement","volume":"30","author":"Osswald","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0090","first-page":"472","article-title":"Predicting risk in transcatheter aortic valve implantation: comparative analysis of EuroSCORE II and established risk stratification tools","volume":"63","author":"Silaschi","year":"2015","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5603\/CJ.a2015.0081","article-title":"Outcome prediction following transcatheter aortic valve implantation: multiple risk scores comparison","volume":"23","author":"Zbronski","year":"2016","journal-title":"Cardiol J"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0100","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.jacc.2010.02.021","article-title":"Natriuretic peptides in common valvular heart disease","volume":"55","author":"Steadman","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.amjcard.2013.11.038","article-title":"Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation","volume":"113","author":"Ribeiro","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0110","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/hrt.2006.096016","article-title":"Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?","volume":"93","author":"Nunez","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2011.02.001","article-title":"Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure","volume":"159","author":"Nunez","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0120","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/eurheartj\/ehq142","article-title":"Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure","volume":"31","author":"Nunez","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.11.020_bib0125","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jchf.2016.06.007","article-title":"Carbohydrate antigen-125-guided therapy in acute heart failure: CHANCE-HF: a randomized study","volume":"4","author":"Nunez","year":"2016","journal-title":"JACC Heart Fail"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917318076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917318076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T15:20:31Z","timestamp":1535210431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917318076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0002914917318076"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.11.020","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}